Ligand validation:5YOT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5YOT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5YOT_NAG_B_811	78%	48%	0.08	0.922	0.61	1.37	-	3	0	0	100%	0.9333
5YOT_NAG_A_809	58%	20%	0.093	0.87	0.82	2.51	-	7	0	0	100%	0.9333
5YOT_NAG_A_810	55%	24%	0.088	0.855	1.17	1.93	-	6	0	0	100%	0.9333
5YOT_NAG_A_811	42%	29%	0.126	0.842	1.1	1.73	2	4	0	0	100%	0.9333
5YOT_NAG_A_813	30%	22%	0.121	0.781	1.04	2.19	1	2	0	0	100%	0.9333
5YOT_NAG_B_812	29%	10%	0.129	0.785	1.53	2.71	3	5	0	0	100%	0.9333
5YOT_NAG_A_808	21%	14%	0.141	0.748	1.25	2.54	2	5	0	0	100%	0.9333
5YOT_NAG_B_810	18%	44%	0.152	0.736	0.74	1.41	1	3	0	0	100%	0.9333
5YOT_NAG_A_812	13%	32%	0.139	0.681	0.97	1.71	2	4	0	0	100%	0.9333
5YOT_NAG_B_813	10%	42%	0.14	0.647	0.87	1.37	1	1	0	0	100%	0.9333
7EAP_NAG_A_805	87%	43%	0.086	0.956	0.86	1.35	-	3	0	0	100%	0.9333
5YQS_NAG_A_804	86%	48%	0.066	0.934	0.49	1.49	-	3	0	0	100%	0.9333
3H0C_NAG_A_796	100%	58%	0.02	0.995	0.47	1.12	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.